|
| |
A Guide to
Achieving Reimbursement for Medical Devices, Diagnostics, and Pharmaceuticals in
the United States
Click to purchase:
A Guide to Achieving Reimbursement for Medical Devices, Diagnostics, and
Pharmaceuticals in the United States
Description:
D&MD's Guide to Achieving Reimbursement explores the basics and lays a
foundation for reimbursement that will assist companies in navigating through
this complex process. In addition, the Guide highlights recent amendments to
legislation that have significantly impacted the industry.
170+
Pages - 18+ Exhibits - 3 Case Studies
|
Reimbursement plays a key role in the success and valuation of a
product- making it crucial for product development decision-makers
to have a sophisticated knowledge of this complex matter.
Reimbursement regulation is a constantly moving target set into
motion by the continuous evolution of legislation (impacting
Medicare and Medicaid) and the private insurance sectors. In
addition, changes within the payer environment have drawn attention
to the accessibility of new technologies to patients.
Companies need to focus on achieving milestones during the
reimbursement process to aid in effectively positioning themselves
for optimal market launch, and for clearly defining and providing
management with a more realistic and credible idea of the value of
their technology. Reimbursement planning should be conducted
concurrently with FDA approval and clinical trials to ensure the
data captured not only addresses the demands of the FDA but also the
requirements of the major insurance carriers to enable a favorable
coverage decision.
D&MD's Guide to Achieving Reimbursement explores the
basics and lays a foundation for reimbursement that will assist
companies in navigating through this complex process. In addition,
the Guide highlights recent amendments to legislation that have
significantly impacted the industry.
This Guide provides all the information crucial for seeking
reimbursement during product development. You will be able to:
-
Learn how to incorporate reimbursement activities into company's
product development cycle and strategic & development plans.
-
Identify and achieve key milestones during the reimbursement
process.
-
Recognize the processes for achieving coverage, coding, and
payment and access the impact of these achievements on the
financial forecast and adoption rates.
-
Assess the benefit of using health economics modeling to establish
value and price.
-
Implement tactics to ensure market adoption is optimized and
health providers receive payment from both private and government
payment systems.
-
Detect the roadways to gaining both public (Medicare and Medicaid)
and private insurance coverage for new medical technologies.
-
Understand the impact of health policy legislation and politics on
devices, drugs, durable medical equipment (DME), and how patients
access new technologies.
|
|
|
|
This Report will prove
beneficial to:
Executives and senior managers at medical device,
diagnostic, biotechnology, and pharmaceutical companies who are
seeking to license, market, and commercialize a product within the
United States healthcare system.
In addition, this Guide will prove invaluable to
commercial reference laboratories, reagent suppliers, equipment
manufacturers, venture capitalists, investment bankers, research
analysts, and other healthcare service professionals wanting an
understanding of the issues within reimbursement and how they will
impact their own, or their portfolio companies.
Valuable Case Studies
Learn the in's and out's of reimbursement from
case studies of three companies.
Medical Device
In Vitro Diagnostic
Drug/Biologic
|
|
|
|
Table of Contents |
|
Section |
Summary |
|
1. |
Introduction: The Role of Reimbursement in the U.S.
Healthcare System
1.1 Overview
1.2 Public Sector
1.3 Private Sector
1.4 Worker's Compensation
1.5 Self-insured Employer Groups
1.6 Supplemental Insurance |
|
2. |
Understanding the Basics
2.1 Site of Care and Reimbursement
2.2 Coverage
2.3 Coding Systems
2.4 Payment Systems |
|
3. |
Health Economics and Reimbursement
3.1. Economic Modeling and Analysis and Clinical Trial Integration
3.2. Formulary Review/Positioning
|
|
4. |
Timeline of Events
|
|
5. |
Reimbursement and Adoption: Tactics
5.1. Hotlines
5.2. Coding and Reimbursement Guides
5.3. Sales Force
|
|
6. |
The Government: Impact on Reimbursement
6.1. Role of Congress
6.2. Centers for Medicare and Medicaid Services (CMS)
6.3. The Food and Drug Administration (FDA)
|
|
7. |
Reimbursement's Impact on Business Strategy
7.1. Strategic Planning
7.2. Clinical Development
7.3. Reimbursement and Valuation
|
|
8. |
Case Studies
8.1. Medical Device
8.2. In Vitro Diagnostic
8.3. Drug/Biologic
|
|
9. |
Coding Application Examples
9.1. Current Procedural Terminology (CPT)
9.2. Healthcare Common Procedure Coding System (HCPCS)
|
|
10. |
Technology Assessment
|
|
11. |
Appendix-Acronyms and Glossary
11.1. Reimbursement Acronyms
11.2. Reimbursement Glossary |
Date published:
7/1/2003
Number of pages:
170+
Category:
Drug Discovery
Industry:
Pharmaceutical & Biotech
Price Hard Copy
(US$):
$395.00
Interested in this
report:
peter.barfoot@bioportfolio.com
| |
|
